• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Jeffrey L. Blumer, Donald L. Batisky, Thomas Wells, Victor Shi, Susan Solar-Yohay, Gangadhar Sunkara
  • Medicine
  • Journal of clinical pharmacology
  • 2009 (First Publication: 1 February 2009)
  • An open-label, single-dose study is conducted in 26 children with hypertension to characterize the pharmacokinetics of valsartan. Valsartan is administered as an oral suspension (dose of 2 mg/kg),Continue Reading
  • Haiying Sun, Lillian S. L. Ting, +7 authors S. Ken Tanaka
  • Medicine
  • Antimicrobial agents and chemotherapy
  • 2016 (First Publication: 10 October 2016)
  • Omadacycline is a first-in-class aminomethylcycline antibiotic with microbiological activity against Gram-positive and Gram-negative aerobes and anaerobes and atypical bacteria that is beingContinue Reading
  • Surya Ayalasomayajula, Wei Pan, +7 authors Gangadhar Sunkara
  • Chemistry, Medicine
  • European Journal of Drug Metabolism and…
  • 2016 (First Publication: 1 April 2017)
  • Background and ObjectiveLCZ696 (sacubitril/valsartan), a novel angiotensin receptor neprilysin inhibitor has been recently approved for the treatment of patients with heart failure (HF) and reducedContinue Reading
  • Gangadhar Sunkara, Christine Vinluan Reynolds, Françoise Pommier, Henri Humbert, Chingming Yeh, Pratapa Prasad
  • Medicine
  • Current medical research and opinion
  • 2007 (First Publication: 1 March 2007)
  • OBJECTIVE The potential for a pharmacokinetic drug interaction between valsartan, an antihypertensive drug, and simvastatin, a lipid-lowering agent, was investigated in this study. This was anContinue Reading
  • Kenneth M Kulmatycki, Imad Hanna, +8 authors Jin Chen
  • Chemistry, Medicine
  • International journal of clinical pharmacology…
  • 2015 (First Publication: 1 May 2015)
  • OBJECTIVE An in vitro drugdrug interaction (DDI) study was performed to assess the potential for pradigastat to inhibit breast cancer resistance protein (BCRP), organic anion-transporting polypeptideContinue Reading